Discover Tema ETFs

Managed to pursue better outcomes

Our Exchange Traded Funds

  • Overview
  • Performance
  • Documents
Funds
Name
Fund Category
Price (NAV USD)
Inception Date
Total Net Assets
Net Expense Ratio*
# Holdings
Factsheet
American Reshoring ETF
RSHO
Strategic Equity
$38.73
05/10/23
$127.8M
0.75%
30
GLP-1_Obesity and Cardiometabolic ETF
HRTS
Healthcare
$34.46
11/20/23
$85.5M
0.75%
45
Oncology ETF
CANC
Healthcare
$28.61
08/14/23
$49.8M
0.75%
50
Neuroscience and Mental Health ETF
MNTL
Healthcare
$27.51
01/22/24
$12.1M
0.75%
47
Monopolies and Oligopolies ETF
TOLL
Strategic Equity
$33.38
05/10/23
$12.0M
0.55%
35
Luxury ETF
LUX
Strategic Equity
$23.06
05/10/23
$2.8M
0.75%
44

*Gross expense ratio for RSHO, LUX, HRTS, CANC, MNTL is 0.99%, and 0.55% for TOLL.
RSHO, LUX have a contractual expense cap for net expense ratio of 0.75% in effect through 06/28/2025.
HRTS, CANC, MNTL have a contractual expense cap for net expense ratio of 0.75% in effect through 06/28/2027.

As of 09/30/2024
Funds
Name
3 months
1Y (%)
3Y (%)
5Y (%)
Since Inception (%)
Inception Date
American Reshoring ETF
RSHO
10.00%
36.51%
34.27%
05/10/2023
Monopolies and Oligopolies ETF
TOLL
7.51%
36.36%
23.92%
05/10/2023
Luxury ETF
LUX
0.99%
8.71%
-3.27%
05/10/2023
Neuroscience and Mental Health ETF
MNTL
2.39%
3.89%
01/22/2024
Oncology ETF
CANC
5.29%
23.04%
11.85%
08/14/2023
GLP-1_Obesity and Cardiometabolic ETF
HRTS
0.52%
26.77%
11/20/2023

Performance based on NAV, not market price.

Performance data quoted represents past performance and is no guarantee of future results. Investment return and principal value of an investment will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance data quoted. Returns for periods of less than one year are not annualized.

For the most recent standardized and month end performance for each fund, please click on the respective fund names where these performance metrics can be found.

Funds
Name
Factsheet
Summary Prospectus
Investment Case
Statuary Prospectus
SAI
Annual Report
Semi-Annual Report
Q3 2024 Portfolio Holdings
Monopolies and Oligopolies ETF
American Reshoring ETF
GLP-1_Obesity and Cardiometabolic ETF
Neuroscience and Mental Health ETF